BMS, AstraZeneca Pay AWP Plaintiffs Double Damages

Law360, New York (November 6, 2007, 12:00 AM EST) -- A federal judge has ordered AstraZeneca and Bristol-Myers Squibb to pay Massachusetts plaintiffs in the average wholesale drug price multidistrict litigation $12.9 million and $695,594, respectively, doubling the damages requested after finding that the drug companies knowingly and willfully inflated the average wholesale prices for specific drugs.

On Thursday, Judge Patti B. Saris of the U.S. District Court for the District of Massachusetts awarded damages to two classes of plaintiffs in the multidistrict litigation, both of which represent Massachusetts-based third-party payors of medical insurance. Judge Saris...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.